Pacer Advisors
RCEL icon

Pacer Advisors’s Avita Medical RCEL Stock Holding History

Pacer Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-244
Closed -$3.91K – 3782
2024
Q1 		$3.91K Buy
+244
New +$3.95K ﹤0.01% 3607
2021
Q2 		– Sell
-697
Closed -$14K – 1527
2021
Q1 		$14K Buy
697
+96
+16% +$2.23K ﹤0.01% 1511
2020
Q4 		$11K Buy
+601
New +$13.2K ﹤0.01% 1496

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pacer Advisors's RCEL Position: Q2 2024 in Review

Pacer Advisors sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 244 shares — an estimated $3.91K sold.

Pacer Advisors first reported a position in RCEL in Q4 2020 and held it in 3 quarters. The position peaked at $14K in Q1 2021. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Pacer Advisors reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Pacer Advisors sold 244 Avita Medical shares in Q2 2024, an estimated $3.91K.
  • Pacer Advisors first reported a position in Avita Medical in Q4 2020 and held it in 3 quarters.
  • Pacer Advisors's Avita Medical position peaked at $14K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.